HTA for Precision Medicines: Evaluating the Impact of Testing Practices, Prognostic Markers, and Other Elements of Value
The market for precision medicine has grown exponentially and continues to grow. Precision medicine considers individual patient characteristics such as their genes, environments and lifestyles to provide tailored treatment options. In this article, we explore the key areas relevant to the economic evaluation of precision medicines and offer practical modelling recommendations based on our experience.
Whitepaper
Jan 7, 2022
